Table 2. Gene expression of 20 probe sets associated with disease progression or death due to OSCC, University of Washington Affiliated Medical Centers, 2003–2010.

Probe ID	Gene Symbol	HR*	95% CI		p-value	Coefficient in the Cox model**
225105_at	OCC1	1.9	1.5	2.4	4.00E-07	0.46727
218854_at	SART2	3.0	1.9	4.6	5.80E-07	0.22577
208636_at	ACTN1	2.3	1.6	3.3	1.90E-06	0.47392
212589_at	RRAS2	2.5	1.7	3.8	6.80E-06	0.61303
201474_s_at	ITGA3	2.1	1.5	2.9	6.90E-06	−0.10248
201976_s_at	MYO10	1.9	1.4	2.6	7.70E-06	0.16939
204334_at	KLF7	2.1	1.5	2.9	2.30E-05	0.59466
214853_s_at	SHC1	2.7	1.7	4.3	6.00E-05	0.59933
1552277_a_at	MSANTD3	2.2	1.5	3.3	6.10E-05	0.63538
202896_s_at	SIRPA	2.3	1.5	3.5	6.10E-05	−0.48287
225795_at	C22orf32	0.3	0.2	0.6	7.70E-05	−0.60779
202872_at	ATP6V1C1	2.6	1.6	4.2	9.00E-05	0.44730
205122_at	TMEFF1	1.5	1.2	1.8	1.00E-04	−0.16921
213139_at	SNAI2	2.1	1.4	3.0	1.00E-04	−0.59571
228914_at	MSANTD3-TMEFF1	2.2	1.4	3.3	2.30E-04	−0.29491
235492_at	RNF217	1.9	1.3	2.7	2.80E-04	−0.23651
221898_at	PDPN	1.5	1.2	1.9	2.90E-04	−0.19016
202599_s_at	NRIP1	1.9	1.3	2.7	3.00E-04	0.16372
206581_at	BNC1	1.7	1.3	2.3	4.80E-04	−0.25078
1558152_at	LOC100131262	1.5	1.2	2.0	6.10E-04	−0.15511

^*Hazard ratio of each gene from Cox regression analysis adjusting for age, sex, tumor stage, and high-risk HPV status.

^**Cox model incorporating 20 probe sets, used for calculating a risk score.